TickerFactsScreenerDevelopers

Celldex Therapeutics, Inc. (CLDX) — Total Liabilities

Annual figures by fiscal year, from SEC filings.

2010: $34.69M2011: $29.27M2012: $29.77M2013: $27.30M2014: $36.35M2015: $47.48M2016: $117.93M2017: $79.25M2018: $31.75M2019: $28.91M2020: $26.48M2021: $25.18M2022: $26.53M2023: $36.46M2024: $45.34M2025: $55.82M$55.82M
2010Total Liabilities (USD)2025
Fiscal YearTotal LiabilitiesChange YoY
2025$55.82M+23.1%
2024$45.34M+24.4%
2023$36.46M+37.4%
2022$26.53M+5.4%
2021$25.18M-4.9%
2020$26.48M-8.4%
2019$28.91M-9.0%
2018$31.75M-59.9%
2017$79.25M-32.8%
2016$117.93M+148.4%
2015$47.48M+30.6%
2014$36.35M+33.2%
2013$27.30M-8.3%
2012$29.77M+1.7%
2011$29.27M-15.6%
2010$34.69M—